Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: Long-term follow-up of survival in a randomised trial

The Lancet Oncology

Volumn 17, Issue 2, 2016, Pages 184-192

  Hayes, Andrew J ^a   Maynard, Lauren ^b   Coombes, Gillian ^b   Newton Bishop, Julia ^c   Timmons, Michael ^d   Cook, Martin ^e   Theaker, Jeffrey ^f   Bliss, Judith M ^b   Meirion Thomas, J ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d BRADFORD ROYAL INFIRMARY   (United Kingdom)

^e ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^f UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CUTANEOUS MELANOMA; DEATH; DISEASE SPECIFIC SURVIVAL; EXCISION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NARROW EXCISION; OVERALL SURVIVAL; POLAND; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOUTH AFRICA; SURGICAL TECHNIQUE; TUMOR VOLUME; UNITED KINGDOM; WIDE EXCISION; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; MELANOMA; MIDDLE AGED; MORTALITY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; SKIN NEOPLASMS; SKIN SURGERY; SURVIVAL RATE; TIME FACTOR;

AGED; DERMATOLOGIC SURGICAL PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SKIN NEOPLASMS; SURVIVAL RATE; TIME FACTORS;

EID: 84959369551     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(15)00482-9     Document Type: Article

References (22)

1. Thompson JF, Soong SJ, Balch CM, et al. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol 2011, 29:2199-2205.
2. Soong SJ, Ding S, Coit D, et al. Predicting survival outcome of localized melanoma: an electronic prediction tool based on the AJCC Melanoma Database. Ann Surg Oncol 2010, 17:2006-2014.
3. Cohn-Cedermark G, Rutqvist LE, Andersson R, et al. Long term results of a randomised study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0·8-2·0 mm. Cancer 2000, 89:1495-1501.
4. Balch CM, Soong SJ, Smith T, et al. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol 2001, 8:101-108.
5. Khayat D, Rixe O, Martin G, et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2·1-mm thick). Cancer 2003, 97:1941-1946.
6. Gillgren P, Drzewiecki KT, Niin M, et al. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial. Lancet 2011, 378:1635-1642.
7. Veronesi U, Cascinelli N, Adamus J, et al. Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm. N Engl J Med 1988, 318:1159-1162.
8. Handley WS The pathology of melanotic growths in relation to their operative treatment. Lancet 1907, 169:996-1003.
9. Olsen G The malignant melanoma of the skin. New theories based on a study of 500 cases. Acta Chir Scand Suppl 1966, 365:1-222.
10. Thomas JM, Newton-Bishop J, A'Hern R, et al. Excision margins in high risk malignant melanoma. N Engl J Med 2004, 350:757-766.
11. Kaplan EL, Meier P Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958, 53:457-481.
12. Cox DR Regression models and life-tables. J R Stat Soc B 1972, 34:187-220.
13. Fine JP, Gray RJ A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
14. Gray RJ A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988, 16:1141-1154.
15. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009, 27:6199-6206.
16. Hudson LE, Maithel SK, Carlson GW, et al. 1 or 2 cm margins of excision for T2 melanomas: do they impact recurrence or survival?. Ann Surg Oncol 2013, 20:346-351.
17. Cascinelli N, Morabito A, Santinami M, et al. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 1998, 351:793-796.
18. Coates AS, Ingvar CI, Petersen-Schaefer K, et al. Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma Unit from 1960 to 1991. J Am Coll Surg 1995, 180:402-409.
19. Sim FH, Taylor WF, Pritchard DJ, Soule EH Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomised study. Mayo Clin Proc 1986, 61:697-705.
20. Balch CM, Soong SJ, Ross MI, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1·0 to 4·0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 2000, 7:87-97.
21. Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med 1977, 297:627-630.
22. Morton DL, Thompson JF, Cochran AJ, et al. Final report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med 2014, 370:599-609.